Erythroid glucose transporters

Current Opinion in Hematology

Volumn 16, Issue 3, 2009, Pages 165-172

  Montel Hagen, Amélie ^a   Sitbon, Marc ^a   Taylor, Naomi ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

Dehydroascorbic acid; Erythrocyte; Evolution; Glucose transport; Glucose transporter

Indexed keywords

ASCORBIC ACID; DEHYDROASCORBIC ACID; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; STOMATIN;

ENZYME SPECIFICITY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE METABOLISM; ERYTHROID CELL; GLUCOSE TRANSPORT; HEXOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; ASCORBIC ACID; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; ERYTHROCYTES; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MAMMALS;

EID: 67650983450     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328329905c     Document Type: Review

References (76)

1. Mueckler M. Facilitative glucose transporters. Eur J Biochem 1994; 219: 713-725.
2. May JM. Ascorbate function and metabolism in the human erythrocyte. Front Biosci 1998; 3:d1-d10.
3. Montel-Hagen A, Kinet S, Manel N, et al. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell 2008; 132:1039-1048. Our publication showing that erythrocyte GLUT1 promotes the preferential uptake of DHA and is specific to vitamin C-deficient mammals.
4. Wright EM, Loo DD, Panayotova-Heiermann M, et al. 'Active' sugar transport in eukaryotes. J Exp Biol 1994; 196:197-212.
5. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 2001; 18:247-256.
6. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003; 89:3-9.
7. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005; 202:654-662.
8. Zhao FQ, Keating AF. Functional properties and genomics of glucose transporters. Curr Genomics 2007; 8:113-128. Excellent recent review on GLUTs.
9. Mueckler M, Caruso C, Baldwin SA, et al. Sequence and structure of a human glucose transporter. Science 1985; 229:941-945.
10. Mueckler M, Makepeace C. Cysteine-scanning mutagenesis and substituted cysteine accessibility analysis of transmembrane segment 4 of the Glut1 glucose transporter. J Biol Chem 2005; 280:39562-39568.
11. Teerijoki H, Krasnov A, Pitkanen TI, Molsa H. Cloning and characterization of glucose transporter in teleost fish rainbow trout (Oncorhynchus mykiss). Biochim Biophys Acta 2000; 1494:290-294.
12. Warburg O. On the origin of cancer cells. Science 1956; 123:309-314.
13. Zhang JZ, Behrooz A, Ismail-Beigi F. Regulation of glucose transport by hypoxia. Am J Kidney Dis 1999; 34:189-202.
14. Rea S, James DE. Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 1997; 46:1667-1677.
15. Burant CF, Takeda J, Brot-Laroche E, et al. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 1992; 267:14523-14526.
16. Uldry M, Ibberson M, Horisberger JD, et al. Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain. Embo J 2001; 20:4467-4477.
17. Bianchi J, Rose RC. Glucose-independent transport of dehydroascorbic acid in human erythrocytes. Proc Soc Exp Biol Med 1986; 181:333-337.
18. Vera JC, Rivas CI, Fischbarg J, Golde DW. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 1993; 364:79-82.
19. Rumsey SC, Kwon O, Xu GW, et al. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem 1997; 272:18982-18989.
20. Rumsey SC, Daruwala R, Al-Hasani H, et al. Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes. J Biol Chem 2000; 275:28246-28253.
21. McNulty AL, Stabler TV, Vail TP, et al. Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint. Arthritis Rheum 2005; 52:2676-2685.
22. Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008; 40:437-442. Recent identification that GLUT9 preferentially transports urate rather than glucose.
23. Caulfield MJ, Munroe PB, O'Neill D, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008; 5:e197. Recent identification that GLUT9 preferentially transports urate rather than glucose.
24. Doege H, Bocianski A, Joost HG, Schurmann A. Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 2000; 350 (Pt 3):771-776.
25. Keembiyehetty C, Augustin R, Carayannopoulos MO, et al. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are upregulated in diabetes. Mol Endocrinol 2006; 20:686-697.
26. Kasahara M, Hinkle PC. Reconstitution and purification of the D-glucose transporter from human erythrocytes. J Biol Chem 1977; 252:7384-7390.
27. Chakrabarti R, Jung CY, Lee TP, et al. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 1994; 152:2660-2668.
28. Rathmell JC, Vander Heiden MG, Harris MH, et al. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell 2000; 6:683-692.
29. Swainson L, Kinet S, Manel N, et al. Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis. Proc Natl Acad Sci U S A 2005; 102:12867-12872.
30. Swainson L, Kinet S, Mongellaz C, et al. IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. Blood 2007; 109:1034-1042.
31. Davies A, Ciardelli TL, LienhardGE, et al. Site-specific antibodies as probes of the topology and function of the human erythrocyte glucose transporter. Biochem J 1990; 266:799-808.
32. Afzal I, Browning JA, Drew C, et al. Effects of anti-GLUT antibodies on glucose transport into human erythrocyte ghosts. Bioelectrochemistry 2004; 62:195-198.
33. Naftalin RJ, Rist RJ. Re-examination of hexose exchanges using rat erythrocytes: evidence inconsistent with a one-site sequential exchange model, but consistent with a two-site simultaneous exchange model. Biochim Biophys Acta 1994; 1191:65-78.
34. Leitch J, Carruthers A. ATP-dependent sugar transport complexity in human erythrocytes. Am J Physiol Cell Physiol 2007; 292:C974-C986.
35. Whitesell RR, Regen DM. Glucose transport characteristics of quiescent thymocytes. J Biol Chem 1978; 253:7289-7294.
36. Garcia JC, Strube M, Leingang K, et al. Amino acid substitutions at tryptophan 388 and tryptophan 412 of the HepG2 (Glut1) glucose transporter inhibit transport activity and targeting to the plasma membrane in Xenopus oocytes. J Biol Chem 1992; 267:7770-7776.
37. Schurmann A, Keller K, Monden I, et al. Glucose transport activity and photolabelling with 3-[125I]iodo-4-azidophenethylamido-7-O-succinyldeacetyl (IAPS)-forskolin of two mutants at tryptophan-388 and -412 of the glucose transporter GLUT1: dissociation of the binding domains of forskolin and glucose. Biochem J 1993; 290 (Pt 2):497-501.
38. Salas-Burgos A, Iserovich P, Zuniga F, et al. Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules. Biophys J 2004; 87:2990-2999.
39. Manel N, Kim FJ, Kinet S, et al. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 2003; 115:449-459.
40. Kim FJ, Seiliez I, Denesvre C, et al. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus. J Biol Chem 2000; 275:23417-23420.
41. Kim FJ, Manel N, Garrido EN, et al. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology 2004; 1:41.
42. Kinet S, Swainson L, Lavanya M, et al. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Retrovirology 2007; 4:31.
43. Manel N, Battini JL, Sitbon M. Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1. J Biol Chem 2005; 280:29025-29029.
44. Montel-Hagen A, Blanc L, Boyer-Clavel M, et al. The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood 2008; 112:4729-4738. Our study showing that erythrocytes of vitamin C-synthesizing species lose GLUT1 during the neonatal period and glucose uptake is thereafter achieved by GLUT4.
45. Socolovsky M, Nam H, Fleming MD, et al. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 2001; 98:3261-3273.
46. Madan A, Varma S, Cohen HJ. Developmental stage-specific expression of the alpha and beta subunits of the HIF-1 protein in the mouse and human fetus. Mol Genet Metab 2002; 75:244-249.
47. Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab 2007; 5:237-252.
48. Sawada K, Krantz SB, Dessypris EN, et al. Human colony-forming unitserythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989; 83:1701-1709.
49. Dolznig H, Habermann B, Stangl K, et al. Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts. Curr Biol 2002; 12:1076-1085.
50. Ratajczak J, Zhang Q, Pertusini E, et al. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions - comparison to other cytokines and growth factors. Leukemia 1998; 12:371-381.
51. Fandos C, Sanchez-Feutrie M, Santalucia T, et al. GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis. J Mol Biol 1999; 294:103-119.
52. Santalucia T, Boheler KR, Brand NJ, et al. Factors involved inGLUT-1 glucose transporter gene transcription in cardiac muscle. J Biol Chem 1999; 274:17626-17634.
53. Im SS, Kwon SK, Kim TH, et al. Regulation of glucose transporter type 4 isoform gene expression in muscle and adipocytes. IUBMB Life 2007; 59:134-145.
54. Mendiratta S, Qu ZC, May JM. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med 1998; 24:789-797.
55. Evans RM, Currie L, Campbell A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. Br J Nutr 1982; 47:473-482.
56. Dhariwal KR, Hartzell WO, Levine M. Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 1991; 54:712-716.
57. Salzer U, Mairhofer M, Prohaska R. Stomatin: a new paradigm of membrane organization emerges. Dyn Cell Biol 2007; 1:20-33.
58. Zhang JZ, Hayashi H, Ebina Y, et al. Association of stomatin (band 7.2b) with Glut1 glucose transporter. Arch Biochem Biophys 1999; 372:173-178.
59. Zhang JZ, Abbud W, Prohaska R, Ismail-Beigi F. Overexpression of stomatin depressesGLUT-1 glucose transporter activity.AmJ Physiol Cell Physiol 2001; 280:C1277-C1283.
60. Kumar A, Xiao YP, Laipis PJ, et al. Glucose deprivation enhances targeting of GLUT1 to lipid rafts in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2004; 286:E568-E576.
61. Bruce LJ, Guizouarn H, Burton NM, et al. The monovalent cation leak in overhydrated stomatocytic red blood cells results from amino acid substitutions in the Rh associated glycoprotein (RhAG). Blood 2009; 113:1350-1357.
62. Khan AA, Hanada T, Mohseni M, et al. Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1. J Biol Chem 2008; 283: 14600-14609.
63. Baumann CA, Ribon V, Kanzaki M, et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000; 407:202-207.
64. Kimura A, Baumann CA, Chiang SH, Saltiel AR. The sorbin homology domain: a motif for the targeting of proteins to lipid rafts. Proc Natl Acad Sci U S A 2001; 98:9098-9103.
65. Fecchi K, Volonte D, Hezel MP, et al. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J 2006; 20:705-707.
66. Chatterjee IB, Kar NC,Ghosh NC, Guha BC. Biosynthesis of L-ascorbic acid: missing steps in animals incapable of synthesizing the vitamin. Nature 1961; 192:163-164.
67. Stone I. Hypoascorbemia, the genetic disease causing the human requirement for exogenous ascorbic acid. Perspect Biol Med 1966; 10:133-134.
68. Burns JJ. Missing step in man, monkey and guinea pig required for the biosynthesis of L-ascorbic acid. Nature 1957; 180:553.
69. MayJM,QuZC, WhitesellRR. Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes. Biochemistry 1995; 34:12721-12728.
70. Nishikimi M, Kawai T, Yagi K. Guinea pigs possess a highly mutated gene for L-gulono-gamma-lactone oxidase, the key enzyme for L-ascorbic acid biosynthesis missing in this species. J Biol Chem 1992; 267:21967-21972.
71. Nishikimi M, Fukuyama R, Minoshima S, et al. Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man. J Biol Chem 1994; 269:13685-13688.
72. Nakajima Y, Shantha TR, Bourne GH. Histochemical detection of L-gulonolactone: phenazine methosulfate oxidoreductase activity in several mammals with special reference to synthesis of vitamin C in primates. Histochemie 1969; 18:293-301.
73. Pollock JI, Mullin RJ. Vitamin C biosynthesis in prosimians: evidence for the anthropoid affinity of Tarsius. Am J Phys Anthropol 1987; 73:65-70.
74. Chatterjee IB. Evolution and the biosynthesis of ascorbic acid. Science 1973; 182:1271-1272.
75. Stone I. Eight decades of scurvy. Australas Nurses J 1979; 8:28-30.
76. Ching S, Mahan DC, Ottobre JS, Dabrowski K. Ascorbic acid synthesis in fetal and neonatal pigs and in pregnant and postpartum sows. J Nutr 2001; 131:1997-2001.